Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML

✍ Scribed by Kantarjian, Hagop M.; Sekeres, Mikkael A.; Ribrag, Vincent; Rousselot, Philippe; Garcia-Manero, Guillermo; Jabbour, Elias J.; Owen, Kate; Stockman, Paul K.; Oliver, Stuart D.

• Book ID: 123386643
• Publisher: Elsevier
• Year: 2013
• Tongue: English
• Weight: 739 KB
• Volume: 13
• Category: Article
• ISSN: 2152-2650
• DOI: 10.1016/j.clml.2013.03.019